- Q2 2023 Pressure Biosciences Inc Earnings Call TranscriptAug 22, 2023$0.29815 (-9.92%)Earnings
- Q1 2023 Pressure Biosciences Inc Earnings Call TranscriptMay 16, 2023$0.9Earnings
- Q4 2022 Pressure Biosciences Inc Earnings Call TranscriptApr 18, 2023$1 (-8.05%)Earnings
- Pressure Biosciences Inc at Emerging Growth Virtual Conference TranscriptMar 22, 2023
- Pressure Biosciences Inc at Issuer Direct Planet MicroCap Showcase (Virtual) TranscriptDec 07, 2022
- Q3 2022 Pressure Biosciences Inc Earnings Call TranscriptNov 22, 2022$1.19 (-6.30%)Earnings
- Pressure Biosciences Inc at LD Micro Main Event TranscriptOct 26, 2022
- Pressure Biosciences Inc at Emerging Growth Conference TranscriptSep 28, 2022
- Q2 2022 Pressure Biosciences Inc Earnings Call TranscriptAug 18, 2022$1.74 (+3.57%)Earnings
- Pressure Biosciences Inc at Emerging Growth Conference TranscriptJul 06, 2022
- Pressure Biosciences Inc Revolutionizing the Development of Plant Based Products TranscriptJun 30, 2022
- Q1 2022 Pressure Biosciences Inc Earnings Call TranscriptMay 19, 2022$1.73 (+1.76%)Earnings
- Q4 2021 Pressure Biosciences Inc Earnings Call TranscriptApr 05, 2022$2 (-2.91%)Earnings
- Pressure Biosciences Inc At Innovations and Advancements in the CBD Market Webinar TranscriptJan 20, 2022
- Pressure Biosciences Inc At Benzinga ALL ACCESS Investor Event TranscriptNov 04, 2021
- Pressure Biosciences Inc at Benzinga Healthcare Small Cap Conference (Virtual) TranscriptSep 30, 2021
- Pressure Biosciences Inc at Emerging Growth Conference TranscriptSep 29, 2021
- Pressure Biosciences Inc at Emerging Growth Conference TranscriptAug 18, 2021
- Q3 2020 Pressure Biosciences Inc Earnings Call TranscriptNov 17, 2020$1.61 (-2.42%)Earnings
Q1 2022 Pressure Biosciences Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Pressure BioSciences first-quarter 2022 financial review and business update. (Operator Instructions) It is now my pleasure to turn the floor over to your host, Richard Schumacher, President and CEO of Pressure BioSciences. Sir, the floor is yours.
Thank you, Matthew, and welcome, everybody, to our first-quarter 2022 financial review and business update.
Before we begin, as always, I'd like to read the following cautionary statement. The following remarks may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements.
Such factors include, among
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)